๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Role of bile acids in splanchnic hemodynamic response to chronic portal hypertension

โœ Scribed by Stephen H. Thomas; Takashi Joh; Joseph N. Benoit

Book ID
112512758
Publisher
Springer US
Year
1991
Tongue
English
Weight
568 KB
Volume
36
Category
Article
ISSN
0163-2116

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Increased expression of endothelin recep
Increased expression of endothelin receptors in the vasculature of portal hypertensive rats: Role in splanchnic hemodynamics
โœ Paul A. Cahill; Ming-chih Hou; Richard Hendrickson; Yi-ning Wang; Shuangmin Zhan ๐Ÿ“‚ Article ๐Ÿ“… 1998 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 178 KB ๐Ÿ‘ 1 views

Portal hypertension (PHT) is characterized by increased portal pressure caused in part by a reduction in mesenteric vascular resistance. The aim of this study was to evaluate the role of endothelin (ET) and specific ET receptors in maintaining the vasculopathy of PHT. PHT was created in Sprague-Dawl

Chronic Bile Duct Ligation in the Dog: H
Chronic Bile Duct Ligation in the Dog: Hemodynamic Characterization of a Portal Hypertensive Model
โœ Jaime Bosch; Rosa Enriquez; Roberto J. Groszmann; Edward H. Storer ๐Ÿ“‚ Article ๐Ÿ“… 2007 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 791 KB

Splanchnic and systemic hemodynamics were measured in six normal dogs and in 18 dogs that had the bile ducts ligated for a period of 8 weeks. In the bile duct-ligated dogs, there was a decrease in arterial pressure (1 10 f 4 mm Hg vs. normal 136 f 6 mm Hg; p < 0.005) and peripheral vascular resistan

Comparison of the hemodynamic responses
Comparison of the hemodynamic responses to ketanserin and prazosin in portal hypertensive rats
โœ Susan A. Cummings; Alberto J. Kaumann; Roberto J. Groszmann ๐Ÿ“‚ Article ๐Ÿ“… 1988 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 529 KB

Ketanserin, a serotonin antagonist, is effective in lowering portal pressure in a rat model of portal hypertension. As ketanserin has al-adrenoceptor-blocking properties in addition to its serotonin-blocking effects, we sought to define further the mechanism of ketanserin's portal pressure-lowering